#PINKPOWER #TRANS #LGBTQIA2S+
Martine #Rothblatt. #MissKitty does not shake her head for this long very often. A totally astounding human being. Over the top amazing!!! 🌈🌈🌈🏳️⚧️🏳️⚧️🏳️⚧️⚧️⚧️⚧️
Martine #Rothblatt. #MissKitty does not shake her head for this long very often. A totally astounding human being. Over the top amazing!!! 🌈🌈🌈🏳️⚧️🏳️⚧️🏳️⚧️⚧️⚧️⚧️
Martine Rothblatt - Wikipedia
en.wikipedia.org
October 27, 2026 at 7:14 PM
#PINKPOWER #TRANS #LGBTQIA2S+
Martine #Rothblatt. #MissKitty does not shake her head for this long very often. A totally astounding human being. Over the top amazing!!! 🌈🌈🌈🏳️⚧️🏳️⚧️🏳️⚧️⚧️⚧️⚧️
Martine #Rothblatt. #MissKitty does not shake her head for this long very often. A totally astounding human being. Over the top amazing!!! 🌈🌈🌈🏳️⚧️🏳️⚧️🏳️⚧️⚧️⚧️⚧️
You can't hear #MissKitty screaming! How can you hate me? 🌈🌈🌈🗽🗽🗽🏳️⚧️🏳️⚧️🏳️⚧️⚧️⚧️⚧️ #PINKS #Trans #LGBTQIA2S+
-
Martine Rothblatt (born 1954) has repeatedly altered commercial technology and public health. In 1990, Rothblatt co-founded Sirius Satellite Radio (Sirius XM), designing satellite constellations ...
-
Martine Rothblatt (born 1954) has repeatedly altered commercial technology and public health. In 1990, Rothblatt co-founded Sirius Satellite Radio (Sirius XM), designing satellite constellations ...
October 27, 2026 at 7:14 PM
You can't hear #MissKitty screaming! How can you hate me? 🌈🌈🌈🗽🗽🗽🏳️⚧️🏳️⚧️🏳️⚧️⚧️⚧️⚧️ #PINKS #Trans #LGBTQIA2S+
-
Martine Rothblatt (born 1954) has repeatedly altered commercial technology and public health. In 1990, Rothblatt co-founded Sirius Satellite Radio (Sirius XM), designing satellite constellations ...
-
Martine Rothblatt (born 1954) has repeatedly altered commercial technology and public health. In 1990, Rothblatt co-founded Sirius Satellite Radio (Sirius XM), designing satellite constellations ...
Martine Rothblatt, Chairperson & CEO of United Therapeutics Corp ($UTHR), just sold $11.1M of company stock.
The median full-time US worker would need 174 years to earn that.
(Sold under a pre-scheduled trading plan.)
The median full-time US worker would need 174 years to earn that.
(Sold under a pre-scheduled trading plan.)
SEC Form 4: United Therapeutics Corp
Insider transaction report filed with the SEC by Martine Rothblatt.
www.sec.gov
October 27, 2026 at 8:40 PM
Martine Rothblatt, Chairperson & CEO of United Therapeutics Corp ($UTHR), just sold $11.1M of company stock.
The median full-time US worker would need 174 years to earn that.
(Sold under a pre-scheduled trading plan.)
The median full-time US worker would need 174 years to earn that.
(Sold under a pre-scheduled trading plan.)
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $588.6415 per common share. (Date: 2026-10-26)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $588.6415 per common share. (Date: 2026-10-26)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 27, 2026 at 8:33 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $588.6415 per common share. (Date: 2026-10-26)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $588.6415 per common share. (Date: 2026-10-26)
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $587.7282 per common share. (Date: 2026-10-27)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $587.7282 per common share. (Date: 2026-10-27)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 28, 2026 at 8:32 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $587.7282 per common share. (Date: 2026-10-27)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $587.7282 per common share. (Date: 2026-10-27)
...United Therapeutics developed treprostinil formulations that turned PAH from an untreatable fatal condition into a manageable disease, preserving tens of thousands of lives worldwide.
Rothblatt also helped pioneer aviation electrification—establishing world records for ...
Rothblatt also helped pioneer aviation electrification—establishing world records for ...
October 27, 2026 at 7:14 PM
...United Therapeutics developed treprostinil formulations that turned PAH from an untreatable fatal condition into a manageable disease, preserving tens of thousands of lives worldwide.
Rothblatt also helped pioneer aviation electrification—establishing world records for ...
Rothblatt also helped pioneer aviation electrification—establishing world records for ...
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $582.7616 per common share. (Date: 2026-10-23)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $582.7616 per common share. (Date: 2026-10-23)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 26, 2026 at 8:33 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $582.7616 per common share. (Date: 2026-10-23)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $582.7616 per common share. (Date: 2026-10-23)
...that enabled coast-to-coast digital vehicular audio broadcasting.
When her young daughter was diagnosed with terminal pulmonary arterial hypertension (PAH), Rothblatt pivoted into medical biotechnology, establishing United Therapeutics in 1996. Under her direction as Chairman and CEO, ...
When her young daughter was diagnosed with terminal pulmonary arterial hypertension (PAH), Rothblatt pivoted into medical biotechnology, establishing United Therapeutics in 1996. Under her direction as Chairman and CEO, ...
October 27, 2026 at 7:14 PM
...that enabled coast-to-coast digital vehicular audio broadcasting.
When her young daughter was diagnosed with terminal pulmonary arterial hypertension (PAH), Rothblatt pivoted into medical biotechnology, establishing United Therapeutics in 1996. Under her direction as Chairman and CEO, ...
When her young daughter was diagnosed with terminal pulmonary arterial hypertension (PAH), Rothblatt pivoted into medical biotechnology, establishing United Therapeutics in 1996. Under her direction as Chairman and CEO, ...
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $583.3783 per common share. (Date: 2026-10-22)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $583.3783 per common share. (Date: 2026-10-22)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 23, 2026 at 8:35 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $583.3783 per common share. (Date: 2026-10-22)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $583.3783 per common share. (Date: 2026-10-22)
Insider tape: one buyer, one family of funds. 🕵️ Saba Capital added to two BNY Mellon muni closed-end funds: LEO $1.91M and DSM $1.10M. Sells: Grindr director Zage $7.06M, United Therapeutics CEO Rothblatt $5.16M. Lindblad's $5.61M is yesterday's repeat, excluded. Buys $3.01M vs sells $12.22M.
October 21, 2026 at 12:55 PM
Insider tape: one buyer, one family of funds. 🕵️ Saba Capital added to two BNY Mellon muni closed-end funds: LEO $1.91M and DSM $1.10M. Sells: Grindr director Zage $7.06M, United Therapeutics CEO Rothblatt $5.16M. Lindblad's $5.61M is yesterday's repeat, excluded. Buys $3.01M vs sells $12.22M.
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $553.8674 per common share. (Date: 2026-10-20)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $553.8674 per common share. (Date: 2026-10-20)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 21, 2026 at 8:35 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $553.8674 per common share. (Date: 2026-10-20)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $553.8674 per common share. (Date: 2026-10-20)
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $543.3238 per common share. (Date: 2026-10-19)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $543.3238 per common share. (Date: 2026-10-19)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 20, 2026 at 8:38 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $543.3238 per common share. (Date: 2026-10-19)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $543.3238 per common share. (Date: 2026-10-19)
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $534.6605 per common share. (Date: 2026-10-16)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $534.6605 per common share. (Date: 2026-10-16)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 19, 2026 at 8:42 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $534.6605 per common share. (Date: 2026-10-16)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $534.6605 per common share. (Date: 2026-10-16)
United Therapeutics CEO Martine Rothblatt Sells $10.3 Million in Stock
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics, sold $10.3 million in company stock during…
Read more: https://embers.news/article/united-therapeutics-ceo-martine-rothblatt-sells-103-million-in-stock-491452
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics, sold $10.3 million in company stock during…
Read more: https://embers.news/article/united-therapeutics-ceo-martine-rothblatt-sells-103-million-in-stock-491452
United Therapeutics CEO Martine Rothblatt Sells $10.3 Million in Stock
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics, sold $10.3 million in company stock during October 2026. The transactions followed the exercise of stock options and were executed under a pre-arranged trading plan, according to regulatory filings.
embers.news
October 17, 2026 at 5:50 PM
United Therapeutics CEO Martine Rothblatt Sells $10.3 Million in Stock
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics, sold $10.3 million in company stock during…
Read more: https://embers.news/article/united-therapeutics-ceo-martine-rothblatt-sells-103-million-in-stock-491452
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics, sold $10.3 million in company stock during…
Read more: https://embers.news/article/united-therapeutics-ceo-martine-rothblatt-sells-103-million-in-stock-491452
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $546.6526 per common share. (Date: 2026-10-15)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $546.6526 per common share. (Date: 2026-10-15)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 16, 2026 at 8:36 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $546.6526 per common share. (Date: 2026-10-15)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $546.6526 per common share. (Date: 2026-10-15)
Martine Rothblatt is an American transgender entrepreneur and inventor who co-founded Sirius Satellite Radio and founded United Therapeutics. Her innovations span communications, biotechnology and medical research.
#MartineRothblatt #Innovation #TransVisibility
#MartineRothblatt #Innovation #TransVisibility
October 15, 2026 at 8:00 AM
Martine Rothblatt is an American transgender entrepreneur and inventor who co-founded Sirius Satellite Radio and founded United Therapeutics. Her innovations span communications, biotechnology and medical research.
#MartineRothblatt #Innovation #TransVisibility
#MartineRothblatt #Innovation #TransVisibility
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $539.9866 per common share. (Date: 2026-10-14)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $539.9866 per common share. (Date: 2026-10-14)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 15, 2026 at 8:35 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $539.9866 per common share. (Date: 2026-10-14)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $539.9866 per common share. (Date: 2026-10-14)
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $545.5173 per common share. (Date: 2026-10-13)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $545.5173 per common share. (Date: 2026-10-13)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 14, 2026 at 8:34 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $545.5173 per common share. (Date: 2026-10-13)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $545.5173 per common share. (Date: 2026-10-13)
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $544.9406 per common share. (Date: 2026-10-09)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $544.9406 per common share. (Date: 2026-10-09)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 13, 2026 at 8:36 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $544.9406 per common share. (Date: 2026-10-09)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $544.9406 per common share. (Date: 2026-10-09)
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $550.7017 per common share. (Date: 2026-10-12)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $550.7017 per common share. (Date: 2026-10-12)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 13, 2026 at 8:37 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $550.7017 per common share. (Date: 2026-10-12)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $550.7017 per common share. (Date: 2026-10-12)
United Therapeutics CEO Sells $5.1M in Shares
United Therapeutics (UTHR) CEO Martine Rothblatt has sold company shares worth $5.1 million. The sale involved a total of 15,226 shares at an average price of a…
https://newsstocks.live/news/united-therapeutics-ceo-sells-51m-in-shares #Finance #Markets
United Therapeutics (UTHR) CEO Martine Rothblatt has sold company shares worth $5.1 million. The sale involved a total of 15,226 shares at an average price of a…
https://newsstocks.live/news/united-therapeutics-ceo-sells-51m-in-shares #Finance #Markets
October 11, 2026 at 12:02 AM
United Therapeutics CEO Sells $5.1M in Shares
United Therapeutics (UTHR) CEO Martine Rothblatt has sold company shares worth $5.1 million. The sale involved a total of 15,226 shares at an average price of a…
https://newsstocks.live/news/united-therapeutics-ceo-sells-51m-in-shares #Finance #Markets
United Therapeutics (UTHR) CEO Martine Rothblatt has sold company shares worth $5.1 million. The sale involved a total of 15,226 shares at an average price of a…
https://newsstocks.live/news/united-therapeutics-ceo-sells-51m-in-shares #Finance #Markets
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $534.3072 per common share. (Date: 2026-10-08)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $534.3072 per common share. (Date: 2026-10-08)
SEC Filing: UTHR
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 8:35 PM
🚨 $UTHR
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $534.3072 per common share. (Date: 2026-10-08)
ROTHBLATT MARTINE A (Chairperson & CEO) sold 9,500 shares at an average price of $534.3072 per common share. (Date: 2026-10-08)
United Therapeutics CEO Martine Rothblatt Sells $1.06 Million in Stock
Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics, sold 1,920 shares of company stock on S…
Read more: https://embers.news/article/united-therapeutics-ceo-martine-rothblatt-sells-106-million-in-stock-362419
Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics, sold 1,920 shares of company stock on S…
Read more: https://embers.news/article/united-therapeutics-ceo-martine-rothblatt-sells-106-million-in-stock-362419
United Therapeutics CEO Martine Rothblatt Sells $1.06 Million in Stock
Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics, sold 1,920 shares of company stock on September 30, 2026, for a total value of approximately $1.06 million. The transaction was conducted under a pre-arranged trading plan, which is a standard regulatory mechanism used by corporat
embers.news
October 8, 2026 at 2:13 PM
United Therapeutics CEO Martine Rothblatt Sells $1.06 Million in Stock
Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics, sold 1,920 shares of company stock on S…
Read more: https://embers.news/article/united-therapeutics-ceo-martine-rothblatt-sells-106-million-in-stock-362419
Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics, sold 1,920 shares of company stock on S…
Read more: https://embers.news/article/united-therapeutics-ceo-martine-rothblatt-sells-106-million-in-stock-362419